ESP Block for Postoperative Analgesia in URS Surgery

Launched by NAMIK KEMAL UNIVERSITY · Feb 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a pain management technique called the erector spinae plane (ESP) block, which is being tested to see if it helps reduce pain after flexible ureterorenoscopy (URS) surgery. The researchers want to find out if the ESP block can lower pain levels, decrease the need for strong pain medications (opioids), reduce the need for extra pain relief treatments, and lessen the chances of feeling sick or vomiting after surgery.

To be eligible for this trial, participants should be between 18 and 65 years old and scheduled for elective URS surgery. They should be in good overall health (ASA I-II) and willing to give their consent to participate. During the trial, participants will be randomly assigned to either the ESP block group, where they will receive the block before surgery, or the control group, which will receive standard pain management without the block. Everyone will receive general anesthesia during surgery and additional pain management afterward. The study will compare how well each method works in managing pain and any side effects experienced.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing elective flexible ureterorenoscopy (URS).
• • Age: 18-65 years.
• • ASA I-II.
• • Willing to participate and provide written informed consent.
• Exclusion Criteria:
• • BMI \>35 kg/m².
• • Allergy to local anesthetics.
• • Coagulation disorders or use of anticoagulants.
• • Patients requiring emergency surgery.
• • Patients with infection at the ESP block site.